BHC(SH:600721) Zheng Quan Shi Bao Wang·2025-09-03 14:05Core Viewpoint - Baihua Pharmaceutical (600721) experienced a trading surge, reaching the daily limit with a turnover rate of 9.48% and a transaction volume of 370 million yuan, indicating strong market interest and activity [2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange due to a price deviation of 11.19%, with a net buying amount of 74.85 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total transaction volume of 163 million yuan, with a buying amount of 119 million yuan and a selling amount of 44.15 million yuan, resulting in a net buying of 74.85 million yuan [2]. - The largest buying brokerage was Kaiyuan Securities, which purchased 60.13 million yuan, while the largest selling brokerage was Guotai Junan Securities, which sold 13.35 million yuan [2]. Fund Flow - The stock saw a net inflow of 109 million yuan from major funds, with a significant inflow of 115 million yuan from large orders, while smaller orders experienced a net outflow of 5.72 million yuan [2]. - Over the past five days, the net inflow of major funds totaled 161 million yuan [2]. Financial Performance - On August 22, the company reported its semi-annual results, achieving a revenue of 202 million yuan, representing a year-on-year growth of 2.95%, and a net profit of 25.48 million yuan, reflecting a year-on-year increase of 12.45% [2].